POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 65 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,920,774 | +48.3% | 1,227,216 | +9.7% | 0.00% | – |
| Q2 2023 | $1,969,009 | +172.7% | 1,118,755 | +377.1% | 0.00% | – |
| Q1 2023 | $722,158 | -56.8% | 234,467 | -25.6% | 0.00% | – |
| Q4 2022 | $1,670,210 | +409.2% | 315,134 | +239.0% | 0.00% | – |
| Q3 2022 | $328,000 | +36.7% | 92,967 | 0.0% | 0.00% | – |
| Q2 2022 | $240,000 | -89.9% | 92,967 | -82.5% | 0.00% | – |
| Q1 2022 | $2,381,000 | -35.7% | 531,573 | -2.3% | 0.00% | – |
| Q4 2021 | $3,704,000 | -2.6% | 543,932 | +4.3% | 0.00% | – |
| Q3 2021 | $3,802,000 | -26.2% | 521,513 | +1.5% | 0.00% | – |
| Q2 2021 | $5,150,000 | +19.4% | 513,992 | +13.8% | 0.00% | – |
| Q1 2021 | $4,314,000 | +110.5% | 451,678 | +141.8% | 0.00% | – |
| Q4 2020 | $2,049,000 | +75.4% | 186,799 | +41.9% | 0.00% | – |
| Q3 2020 | $1,168,000 | – | 131,648 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |